Jain, Harsh

SUMMARY OF EXPERIENCE:

Dr. Harsh Jain has a strong research background in drug delivery of nucleotide and oligonucleotide molecules. He has 7+ years of post-Ph.D. experience of working in the Office of Biotechnology Products at US Food and Drug Administration (FDA). From 2014-2018, he reviewed several pre-IND and IND stage protein (e.g., antibodies and enzymes) therapeutic applications submitted to FDA.

MENTORING SERVICES PROVIDED:

“I can help with preparing and reviewing CMC portion of pre-IND and IND applications of protein therapeutics for submission to US FDA. Also, I can help in identifying translational potential of oligonucleotide based therapeutics.”